167 related articles for article (PubMed ID: 33586070)
21. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
22. The current application of ACOSOG Z0011 trial results: Is further implementation of sentinel lymph node intra-operative histopathological examination mandatory in breast cancer patients - a single-centre analysis.
Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Glowacka-Mrotek I; Sowa M; Biedka M; Kolacinska A
Neoplasma; 2018 Mar; 65(3):449-454. PubMed ID: 29788732
[TBL] [Abstract][Full Text] [Related]
23. The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.
Houvenaeghel G; de Nonneville A; Chopin N; Classe JM; Mazouni C; Chauvet MP; Reyal F; Tunon de Lara C; Jouve E; Rouzier R; Daraï E; Gimbergues P; Coutant C; Azuar AS; Villet R; Crochet P; Rua S; Bannier M; Cohen M; Boher JM
Cancer Med; 2023 Feb; 12(4):4023-4032. PubMed ID: 36127853
[TBL] [Abstract][Full Text] [Related]
24. De-escalation of axillary surgery in patients outside Z0011 criteria.
Giannakou A; Gooch J; Gergelis KR; Weiss A
Surgery; 2023 Aug; 174(2):416-418. PubMed ID: 37156648
[TBL] [Abstract][Full Text] [Related]
25. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
[TBL] [Abstract][Full Text] [Related]
26. When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?
Suyoi A; Bains SK; Kothari A; Douek M; Agbaje O; Hamed H; Fentiman I; Pinder S; Purushotham AD
Eur J Cancer; 2014 Mar; 50(4):690-7. PubMed ID: 24331957
[TBL] [Abstract][Full Text] [Related]
27. The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
van Roozendaal LM; de Wilt JH; van Dalen T; van der Hage JA; Strobbe LJ; Boersma LJ; Linn SC; Lobbes MB; Poortmans PM; Tjan-Heijnen VC; Van de Vijver KK; de Vries J; Westenberg AH; Kessels AG; Smidt ML
BMC Cancer; 2015 Sep; 15():610. PubMed ID: 26335105
[TBL] [Abstract][Full Text] [Related]
28. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
[TBL] [Abstract][Full Text] [Related]
29. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
30. Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients?
van la Parra RF; de Wilt JH; Mol SJ; Mulder AH; de Roos WK; Bosscha K
Breast J; 2015; 21(6):621-6. PubMed ID: 26391102
[TBL] [Abstract][Full Text] [Related]
31. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
32. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
Sanders SB; Hoskin TL; Stafford AP; Boughey JC
Ann Surg Oncol; 2022 Nov; 29(12):7769-7778. PubMed ID: 35834142
[TBL] [Abstract][Full Text] [Related]
33. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.
Dengel LT; Van Zee KJ; King TA; Stempel M; Cody HS; El-Tamer M; Gemignani ML; Sclafani LM; Sacchini VS; Heerdt AS; Plitas G; Junqueira M; Capko D; Patil S; Morrow M
Ann Surg Oncol; 2014 Jan; 21(1):22-7. PubMed ID: 23975314
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
Gray RJ; Pockaj BA; Conley CR
Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
[TBL] [Abstract][Full Text] [Related]
35. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer.
Leonard LD; de Araujo TB; Quinn C; Thomas MB; Beaty L; Mott NM; Colborn K; Heelan AA; Tevis SEA; Christian N; Arhendt G; Gleisner AL
Ann Surg Oncol; 2023 Sep; 30(9):5692-5702. PubMed ID: 37326811
[TBL] [Abstract][Full Text] [Related]
36. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
[TBL] [Abstract][Full Text] [Related]
37. ACOSOG Z-0011 criteria impact on axillary surgery for early breast cancer in clinical practice: Evaluation in a retrospective cohort of 1900 patients.
Dolivet E; Loaec C; Johnson A; Renaudeau C; Boiffard F; Dravet F; Brillaud Meflah V; Classe JM
Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():41-45. PubMed ID: 33878635
[TBL] [Abstract][Full Text] [Related]
38. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
[TBL] [Abstract][Full Text] [Related]
39. De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
de Wild SR; van Roozendaal LM; de Wilt JHW; van Dalen T; van der Hage JA; van Duijnhoven FH; Simons JM; Schipper RJ; de Munck L; van Kuijk SMJ; Boersma LJ; Linn SC; Lobbes MBI; Poortmans PMP; Tjan-Heijnen VCG; van de Vijver KKBT; de Vries J; Westenberg AH; Strobbe LJA; Smidt ML
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38597154
[TBL] [Abstract][Full Text] [Related]
40. A positive intramammary lymph node does not mandate a complete axillary node dissection.
Diaz R; Degnim AC; Boughey JC; Nassar A; Jakub JW
Am J Surg; 2012 Feb; 203(2):151-5. PubMed ID: 21788008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
